Literature DB >> 25935553

Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.

Christina A Muzny1, Jane R Schwebke1.   

Abstract

Biofilms are microbial communities of surface-attached cells embedded in a self-produced extracellular matrix. They are of major medical significance because they decrease susceptibility to antimicrobial agents and enhance the spread of antimicrobial resistance. Biofilm-associated bacterial and fungal microorganisms have increasingly been recognized to play a role in multiple infectious diseases, particularly in their persistence and recurrence. More recently, biofilms have also been implicated in vaginal infections, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), particularly in the setting of treatment failure and recurrence. The purpose of this review is to discuss the impact of biofilms on the management and treatment of BV and recurrent VVC and highlight the need for additional research and development of novel therapeutics targeting pathogenic vaginal biofilms.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bacterial vaginosis; biofilms; recurrent vulvovaginal candidiasis; treatment failure

Mesh:

Substances:

Year:  2015        PMID: 25935553      PMCID: PMC4607736          DOI: 10.1093/cid/civ353

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  54 in total

Review 1.  Biofilm, city of microbes.

Authors:  P Watnick; R Kolter
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.

Authors:  Saul R Hymes; Tara M Randis; Thomas Yang Sun; Adam J Ratner
Journal:  J Infect Dis       Date:  2013-02-19       Impact factor: 5.226

3.  Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.

Authors:  Sixto Sanchez; Patricia J Garcia; Katherine K Thomas; Mary Catlin; King K Holmes
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

4.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

5.  Indole-based novel small molecules for the modulation of bacterial signalling pathways.

Authors:  Nripendra Nath Biswas; Samuel K Kutty; Nicolas Barraud; George M Iskander; Renate Griffith; Scott A Rice; Mark Willcox; David StC Black; Naresh Kumar
Journal:  Org Biomol Chem       Date:  2015-01-21       Impact factor: 3.876

6.  Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.

Authors:  Alexander Swidsinski; Yvonne Dörffel; Vera Loening-Baucke; Johannes Schilling; Werner Mendling
Journal:  FEMS Immunol Med Microbiol       Date:  2010-10-19

Review 7.  Vaginitis.

Authors:  J M Sparks
Journal:  J Reprod Med       Date:  1991-10       Impact factor: 0.142

8.  Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; R P Nugent; D A Eschenbach; M A Krohn; R S Gibbs; D H Martin; M F Cotch; R Edelman; J G Pastorek; A V Rao
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

9.  Candida biofilms and the host: models and new concepts for eradication.

Authors:  Hélène Tournu; Patrick Van Dijck
Journal:  Int J Microbiol       Date:  2011-11-14

Review 10.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13
View more
  43 in total

1.  Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.

Authors:  Leighann Sherry; Ryan Kean; Emily McKloud; Lindsay E O'Donnell; Rebecca Metcalfe; Brian L Jones; Gordon Ramage
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  The Chitosan-Based System with Scutellariae baicalensis radix Extract for the Local Treatment of Vaginal Infections.

Authors:  Justyna Chanaj-Kaczmarek; Natalia Rosiak; Daria Szymanowska; Marcin Rajewski; Ewa Wender-Ozegowska; Judyta Cielecka-Piontek
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

Review 3.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 4.  Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.

Authors:  Christina A Muzny; Jane R Schwebke
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 5.  The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases.

Authors:  L Latéy Bradford; Jacques Ravel
Journal:  Virulence       Date:  2016-09-22       Impact factor: 5.882

6.  In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis.

Authors:  Renátó Kovács; Jeanett Holzknecht; Zoltán Hargitai; Csaba Papp; Attila Farkas; Attila Borics; Lilána Tóth; Györgyi Váradi; Gábor K Tóth; Ilona Kovács; Sandrine Dubrac; László Majoros; Florentine Marx; László Galgóczy
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 7.  New perspectives on the topical management of recurrent candidiasis.

Authors:  Ana Carolina S Ré; Jayanaraian F Martins; Marcílio Cunha-Filho; Guilherme M Gelfuso; Carolina P Aires; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2021-01-19       Impact factor: 4.617

8.  Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.

Authors:  Richard M Weeks; Alysha Moretti; Shuang Song; Kathryn E Uhrich; Andrey V Karlyshev; Michael L Chikindas
Journal:  Pathog Dis       Date:  2019-11-01       Impact factor: 3.951

9.  Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jane R Schwebke; Shelly Y Lensing; Jeannette Lee; Christina A Muzny; Angela Pontius; Nicole Woznicki; Tina Aguin; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

Review 10.  Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis.

Authors:  Christina A Muzny; Paweł Łaniewski; Jane R Schwebke; Melissa M Herbst-Kralovetz
Journal:  Curr Opin Infect Dis       Date:  2020-02       Impact factor: 4.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.